|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||
|
||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s3CDB3F68-514E-11EF-8631-A90485CE164B&I=39IZM&T=&OP=Display&O=html&O1=14372264&O2=1000000000273964&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DPrognostic%2520factors%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520cancer%2520treated%2520with%2520gemcitabine%2520alone%2520or%2520gemcitabine%2520plus%2520cisplatin%253A%2520retrospective%2520analysis%2520of%2520a%2520multicenter%2520study%26rft.au%3DAlgin%252C%2520E%26rft.au%3DInal%252C%2520A%26rft.au%3DKos%252C%2520F%2520T%26rft.au%3DYildiz%252C%2520R%26rft.date%3D2012-01-01%26rft.externalDocID%3D22517701%26rft.genre%3Darticle%26rft.issn%3D1107-0625%26rft.issue%3D1%26rft.jtitle%3DJournal%2520of%2520B.U.%2520ON.%26rft.spage%3D102%26rft.volume%3D17%26rft_id%3Dinfo%253Apmid%252F22517701%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MISCELLANEOUS_FREE_EJOURNALS-getFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,5-REFWORKS_EXPORT_TOOL-getReference-object,6-NCBI_PUBMED_FREE-getCitedRecord-object,7-GOOGLE_SCHOLAR_FREE-getWebSearch-object,8-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.791463&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:14372264-s3CDB3F68-514E-11EF-8631-A90485CE164B" timestamp="2024-08-03T06:09:54Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:1000000000273964</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study.</jnl:atitle>
<jnl:jtitle>Journal of Balkan Union of Oncology</jnl:jtitle>
<jnl:date>2012-00-00</jnl:date>
<jnl:spage>102</jnl:spage>
<jnl:epage>105</jnl:epage>
<jnl:issn>1107-0625</jnl:issn>
<jnl:volume>17</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2241-6293</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:7b971f50f59e34b553a89400d7803fa8b27fcb59</ctx:identifier>
<ctx:identifier>urn:UUID:s3CDB3F68-514E-11EF-8631-A90485CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)